Adjuvants and delivery systems in veterinary vaccinology: current state and future developments

Publication: Research - peer-reviewJournal article – Annual report year: 2011

Standard

Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. / Heegaard, Peter M. H.; Dedieu, Laurence; Johnson, Nicholas; Potier, Marie-Frédérique Le; Mockey, Michael; Mutinelli, Franco; Vahlenkamp, Thomas; Vascellari, Marta; Sørensen, Nanna Skall.

In: Archives of Virology, Vol. 156, No. 2, 2011, p. 183-202.

Publication: Research - peer-reviewJournal article – Annual report year: 2011

Harvard

Heegaard, PMH, Dedieu, L, Johnson, N, Potier, M-FL, Mockey, M, Mutinelli, F, Vahlenkamp, T, Vascellari, M & Sørensen, NS 2011, 'Adjuvants and delivery systems in veterinary vaccinology: current state and future developments' Archives of Virology, vol 156, no. 2, pp. 183-202., 10.1007/s00705-010-0863-1

APA

CBE

Heegaard PMH, Dedieu L, Johnson N, Potier M-FL, Mockey M, Mutinelli F, Vahlenkamp T, Vascellari M, Sørensen NS. 2011. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Archives of Virology. 156(2):183-202. Available from: 10.1007/s00705-010-0863-1

MLA

Vancouver

Heegaard PMH, Dedieu L, Johnson N, Potier M-FL, Mockey M, Mutinelli F et al. Adjuvants and delivery systems in veterinary vaccinology: current state and future developments. Archives of Virology. 2011;156(2):183-202. Available from: 10.1007/s00705-010-0863-1

Author

Heegaard, Peter M. H.; Dedieu, Laurence; Johnson, Nicholas; Potier, Marie-Frédérique Le; Mockey, Michael; Mutinelli, Franco; Vahlenkamp, Thomas; Vascellari, Marta; Sørensen, Nanna Skall / Adjuvants and delivery systems in veterinary vaccinology: current state and future developments.

In: Archives of Virology, Vol. 156, No. 2, 2011, p. 183-202.

Publication: Research - peer-reviewJournal article – Annual report year: 2011

Bibtex

@article{fcf54e2d1fab48e0abd14f4fa7d2cce9,
title = "Adjuvants and delivery systems in veterinary vaccinology: current state and future developments",
publisher = "Springer Wien",
author = "Heegaard, {Peter M. H.} and Laurence Dedieu and Nicholas Johnson and Potier, {Marie-Frédérique Le} and Michael Mockey and Franco Mutinelli and Thomas Vahlenkamp and Marta Vascellari and Sørensen, {Nanna Skall}",
note = "The original publication is available at www.springerlink.com.",
year = "2011",
doi = "10.1007/s00705-010-0863-1",
volume = "156",
number = "2",
pages = "183--202",
journal = "Archives of Virology",
issn = "0304-8608",

}

RIS

TY - JOUR

T1 - Adjuvants and delivery systems in veterinary vaccinology: current state and future developments

A1 - Heegaard,Peter M. H.

A1 - Dedieu,Laurence

A1 - Johnson,Nicholas

A1 - Potier,Marie-Frédérique Le

A1 - Mockey,Michael

A1 - Mutinelli,Franco

A1 - Vahlenkamp,Thomas

A1 - Vascellari,Marta

A1 - Sørensen,Nanna Skall

AU - Heegaard,Peter M. H.

AU - Dedieu,Laurence

AU - Johnson,Nicholas

AU - Potier,Marie-Frédérique Le

AU - Mockey,Michael

AU - Mutinelli,Franco

AU - Vahlenkamp,Thomas

AU - Vascellari,Marta

AU - Sørensen,Nanna Skall

PB - Springer Wien

PY - 2011

Y1 - 2011

N2 - Modern adjuvants should induce strong and balanced immune responses, and it is often desirable to induce specific types of immunity. As an example, efficient Th1-immunity-inducing adjuvants are highly in demand. Such adjuvants promote good cell-mediated immunity against subunit vaccines that have low immunogenicity themselves. The development of such adjuvants may take advantage of the increased knowledge of the molecular mechanisms and factors controlling these responses. However, knowledge of such molecular details of immune mechanisms is relatively scarce for species other than humans and laboratory rodents, and in addition, there are special considerations pertaining to the use of adjuvants in veterinary animals, such as production and companion animals. With a focus on veterinary animals, this review highlights a number of approaches being pursued, including cytokines, CpG oligonucleotides, microparticles and liposomes.

AB - Modern adjuvants should induce strong and balanced immune responses, and it is often desirable to induce specific types of immunity. As an example, efficient Th1-immunity-inducing adjuvants are highly in demand. Such adjuvants promote good cell-mediated immunity against subunit vaccines that have low immunogenicity themselves. The development of such adjuvants may take advantage of the increased knowledge of the molecular mechanisms and factors controlling these responses. However, knowledge of such molecular details of immune mechanisms is relatively scarce for species other than humans and laboratory rodents, and in addition, there are special considerations pertaining to the use of adjuvants in veterinary animals, such as production and companion animals. With a focus on veterinary animals, this review highlights a number of approaches being pursued, including cytokines, CpG oligonucleotides, microparticles and liposomes.

UR - http://www.springerlink.com/content/hhu3p42p6384lxl7/

U2 - 10.1007/s00705-010-0863-1

DO - 10.1007/s00705-010-0863-1

JO - Archives of Virology

JF - Archives of Virology

SN - 0304-8608

IS - 2

VL - 156

SP - 183

EP - 202

ER -